No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes

D. Iafusco, C. Bizzarri, F. Cadario, R. Pesavento, G. Tonini, S. Tumini, V. Cauvin, C. Colombo, R. Bonfanti, F. Barbetti

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2736-2738
Number of pages3
JournalDiabetologia
Volume54
Issue number10
DOIs
Publication statusPublished - Oct 2011

Keywords

  • Chronic
  • Durability
  • Efficacy
  • Glibenclamide
  • KCNJ11 gene
  • Kir6.2
  • Mutations
  • Permanent neonatal diabetes
  • Sulfonylurea
  • Therapy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. / Iafusco, D.; Bizzarri, C.; Cadario, F.; Pesavento, R.; Tonini, G.; Tumini, S.; Cauvin, V.; Colombo, C.; Bonfanti, R.; Barbetti, F.

In: Diabetologia, Vol. 54, No. 10, 10.2011, p. 2736-2738.

Research output: Contribution to journalArticle

Iafusco, D. ; Bizzarri, C. ; Cadario, F. ; Pesavento, R. ; Tonini, G. ; Tumini, S. ; Cauvin, V. ; Colombo, C. ; Bonfanti, R. ; Barbetti, F. / No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. In: Diabetologia. 2011 ; Vol. 54, No. 10. pp. 2736-2738.
@article{d5909d061a39417397fcc1ce939dc506,
title = "No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes",
keywords = "Chronic, Durability, Efficacy, Glibenclamide, KCNJ11 gene, Kir6.2, Mutations, Permanent neonatal diabetes, Sulfonylurea, Therapy",
author = "D. Iafusco and C. Bizzarri and F. Cadario and R. Pesavento and G. Tonini and S. Tumini and V. Cauvin and C. Colombo and R. Bonfanti and F. Barbetti",
year = "2011",
month = "10",
doi = "10.1007/s00125-011-2273-7",
language = "English",
volume = "54",
pages = "2736--2738",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes

AU - Iafusco, D.

AU - Bizzarri, C.

AU - Cadario, F.

AU - Pesavento, R.

AU - Tonini, G.

AU - Tumini, S.

AU - Cauvin, V.

AU - Colombo, C.

AU - Bonfanti, R.

AU - Barbetti, F.

PY - 2011/10

Y1 - 2011/10

KW - Chronic

KW - Durability

KW - Efficacy

KW - Glibenclamide

KW - KCNJ11 gene

KW - Kir6.2

KW - Mutations

KW - Permanent neonatal diabetes

KW - Sulfonylurea

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=80054097981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054097981&partnerID=8YFLogxK

U2 - 10.1007/s00125-011-2273-7

DO - 10.1007/s00125-011-2273-7

M3 - Article

C2 - 21822789

AN - SCOPUS:80054097981

VL - 54

SP - 2736

EP - 2738

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -